The journey of Equivac from concept to clinical trials is marked by innovation, collaboration, and an unwavering focus on safety and efficacy. Explore our development timeline and learn about the key phases of research, including preclinical trials, Phase I, II, and III clinical trials, and our plans for future deployment.
Our commitment to transparency and scientific rigor guides every step of Equivac’s development.
Research Team
Our research team is composed of leading scientists, clinicians, and experts in pharmacology and immunology. Together, they bring decades of experience and a shared passion for advancing public health through innovative vaccine development.
